IVERIC bio, Inc.
ISEEDelisted Jul 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410939
IVERIC bio, Inc. was delisted on Jul 11, 2023; its insiders filed their last Form 4 on Jul 13, 2023; 256 institutions reported holding it in 13F filings for Q2 2023, worth $5.33B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding IVERIC bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 150 | 175 | +25 |
| Shares | 103.6M | 120.2M | +16.6M (+16.0%) |
| Value | $1.68B | $2.00B | +$326.7M (+19.5%) |
New holders (40)
Institutions that held IVERIC bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (15)
Institutions that held IVERIC bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Tri Locum Partners LP | 377,708 | $6.13M |
| Octagon Capital Advisors LP | 277,057 | $4.50M |
| Renaissance Technologies LLC | 248,300 | $4.03M |
| Verition Fund Management LLC | 86,710 | $1.41M |
| Jefferies Group LLC | 58,115 | $943.8K |
| SG3 Management, LLC | 40,000 | $650.0K |
| Caption Management, LLC | 32,915 | $535.0K |
| Silverarc Capital Management, LLC | 30,000 | $487.0K |
| Seven Eight Capital, LP | 26,000 | $422.0K |
| Parallax Volatility Advisers, L.P. | 25,927 | $421.0K |
| Boothbay Fund Management, LLC | 21,694 | $352.0K |
| Old Well Partners, LLC | 12,711 | $206.0K |
| Penserra Capital Management LLC | 2,375 | $38.0K |
| Meridian Wealth Partners, LLC | 500 | $8.00K |
| State of Wyoming | 80 | $1.00K |